To include your compound in the COVID-19 Resource Center, submit it here.

Siga signs BARDA contract for smallpox drug worth up to $629M

Siga Technologies Inc. (NASDAQ:SIGA) signed a contract with HHS's Biomedical Advanced Research and Development Authority (BARDA) to deliver oral

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE